Vol 90, No 2 (2019)
Research paper
Published online: 2019-02-28

open access

Page views 3182
Article views/downloads 2642
Get Citation

Connect on Social Media

Connect on Social Media

Hormonal contraception in patients with epilepsy

Magdalena Bosak1, Katarzyna Cyranka1, Agnieszka Slowik1
Pubmed: 30860270
Ginekol Pol 2019;90(2):61-65.

Abstract

Objectives: The aim of the study was to evaluate hormonal contraception use in women with epilepsy and to assess the risk of potential interactions between contraceptives and antiepileptic drugs (AEDs). 

Material and methods: Data on hormonal contraception were obtained prospectively in women of childbearing age treated in the university epilepsy clinic. 

Results: We evaluated 334 women with epilepsy (mean age 30.2 years). The majority of patients took one AED (193, 58%); the most commonly prescribed AEDs were: valproate, levetiracetam or lamotrigine. Hormonal contraception was used by 19 (5.7%) of all women of childbearing age. Only 7 patients (37%) of all those using hormonal contraception used prepa- rations that did not interact with AEDs; what is more 145 (46%) patients who did not use hormonal contraception were prescribed AEDs with high teratogenic potential (valproate or/and topiramate). 

Conclusions: A very small percentage of women with epilepsy of childbearing potential used hormonal contraception. More than a half of that group simultaneously took AEDs that may interact with oral contraceptives. A large proportion of women taking AEDs with high teratogenic potential were not using hormonal contraception. As interaction between OC and AEDs are common, nonhormonal, highly effective methods, such as IUDs, may be ideal for women with epilepsy. The results of the study indicate the need for closer cooperation between neurologist and gynecologist caring for women with epilepsy.

Article available in PDF format

View PDF Download PDF file

References

  1. Jette N, Fiest KM, Sauro KM, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology. 2017; 88(3): 296–303.
  2. EurapInternational http://eurapinternational. http://eurapinternational.org/wp-content/uploads/2018/09/Eurap_Report_May_2018.pdf (2018.09.15).
  3. Reimers A, Brodtkorb E, Sabers A. Interactions between hormonal contraception and antiepileptic drugs: Clinical and mechanistic considerations. Seizure. 2015; 28: 66–70.
  4. Bhakta J, Bainbridge J, Borgelt L. Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy. Epilepsy Behav. 2015; 52(Pt A): 212–217.
  5. Herzog AG, Mandle HB, Cahill KE, et al. Contraceptive practices of women with epilepsy: Findings of the epilepsy birth control registry. Epilepsia. 2016; 57(4): 630–637.
  6. Herzog A, Mandle H, Cahill K, et al. Predictors of unintended pregnancy in women with epilepsy. Neurology. 2017; 88(8): 728–733.
  7. Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014; 55(4): 475–482.
  8. Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017; 58(4): 512–521.
  9. Plany prokreacyjne i stosowanie antykoncepcji przez Polaków w wieku reprodukcyjnym. Zdrowie Publiczne i Zarządzanie. 2017; 15(2).
  10. http://stat.gov.pl/obszary-tematyczne/inne-opracowania/wyznania-religijne/wyznania-religijne-w-polsce-20122014,5,1.html (2018.10.31).
  11. Mandle HB, Cahill KE, Fowler KM, et al. Reasons for discontinuation of reversible contraceptive methods by women with epilepsy. Epilepsia. 2017; 58(5): 907–914.
  12. EuropeanMedicinesAgency. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Valproate_2017_31/European_Commission_final_decision/WC500250216.pdf (2018.09.15).
  13. Tomaszewski J, Paszkowski T, Debski R, et al. [The CHOICE study (Contraceptive Health Research Of Informed Choice Experience)--an educational research program for Polish women planning combined hormonal contraceptives use]. Ginekol Pol. 2012; 83(6): 417–423.
  14. Jędrzejczak J, Bomba-Opoń D, Jakiel G, et al. Managing epilepsy in women of childbearing age - Polish Society of Epileptology and Polish Gynecological Society Guidelines. Ginekol Pol. 2017; 88(5): 278–284.
  15. Reddy DS. Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives. Expert Rev Clin Pharmacol. 2010; 3(2): 183–192.
  16. Reimers A. Contraception for women with epilepsy: counseling, choices, and concerns. Open Access J Contracept. 2016; 7: 69–76.
  17. Herzog AG, Mandle HB, Cahill KE, et al. Differential impact of contraceptive methods on seizures varies by antiepileptic drug category: Findings of the Epilepsy Birth Control Registry. Epilepsy Behav. 2016; 60: 112–117.
  18. Vieira CS, Pack A, Roberts K, et al. A pilot study of levonorgestrel concentrations and bleeding patterns in women with epilepsy using a levonorgestrel IUD and treated with antiepileptic drugs. Contraception. 2018 [Epub ahead of print].